Histone deacetylase inhibitors in multiple myeloma

Novel drugs such as bortezomib and high-dose chemotherapy combined with stem cell transplantation improved the outcome of multiple myeloma patients in the past decade. However, multiple myeloma often remains incurable due to the development of drug resistance governed by the bone marrow microenviron...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Deleu, Sarah, Menu, Eline, Valckenborgh, Els Van, Van Camp, Ben, Fraczek, Joanna, Vande Broek, Isabelle, Rogiers, Vera, Vanderkerken, Karin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: PAGEPress Publications 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3222248/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2009.e9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg